Total medical devices industry deals in Q4 2018 worth $13.23bn were announced, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 2.1% over the previous quarter and a rise of 6% when compared with the last four-quarter average of $12.48bn.

In terms of number of deals, the sector saw a drop of 20.52% over the last four-quarter average with 275 deals against the average of 346 deals.

In value terms, North America led the activity with deals worth $6.98bn.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The top five medical devices deals accounted for 71.16% of the overall value in the sector globally during Q4 2018.

The combined value of the top five medical devices deals stood at $9.42bn, against the overall value of $13.23bn recorded for the quarter.

Medical devices industry deals in Q4 2018: Top deals

The top announced medical devices deal tracked by GlobalData in Q4 2018 was Bravo Bidco’s $4.24bn acquisition of BTG.

In second place was Colfax’s acquisition of DJO Global for $3.15bn and in third place was Astorg Partners’ $1.16bn private equity deal with Nemera La Verpilliere.

Gurnet Point Capital’s $504m private equity deal with Corium International and ConMed Corp’s acquisition of Buffalo Filter LLC for $365m held fourth and fifth positions, respectively.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

Verdict’s parent company GlobalData plc provides business information to 4,000 of the world’s largest companies.